MADONA: Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain

Sponsor
Université du Québec a Montréal (Other)
Overall Status
Unknown status
CT.gov ID
NCT00736346
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
204
3
4
56
68
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the impact of three different treatment modalities on panic symptoms, quality of life and use of health services among individuals consulting an emergency department for non cardiac chest pain and having Panic Disorder.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Brief cognitive-behavioral treatment for Panic Disorder
  • Behavioral: Cognitive-Behavior Therapy for Panic Disorder
  • Drug: paroxetine
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
204 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of Three Treatment Modalities for Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
Study Start Date :
Oct 1, 2005
Anticipated Primary Completion Date :
Dec 1, 2009
Anticipated Study Completion Date :
Jun 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Behavioral: Brief cognitive-behavioral treatment for Panic Disorder
One two-hour session of cognitive-behavior therapy for panic disorder

Active Comparator: 2

Behavioral: Cognitive-Behavior Therapy for Panic Disorder
Seven one-hour sessions of cognitive-behavior therapy for panic disorder

Active Comparator: 3

Drug: paroxetine
40 mg die, for 6 months

No Intervention: 4

Outcome Measures

Primary Outcome Measures

  1. Panic Disorder diagnosis [Pre and posttreatment, and 3, 6 and 12 months after treament]

Secondary Outcome Measures

  1. Panic symptomatology, psychological distress, quality of life, and use of health services [Pre and posttreatment, and 3, 6 and 12 months after treatment]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 18 and over

  • Mastered oral and written French

  • Consulted an emergency department for chest pain with very low risk of coronary disease (normal ECG and blood tests)

  • Met criteria for Panic Disorder

Exclusion Criteria:
  • Chest pain with an obvious medical origin (obvious trauma or abnormal pulmonary x-rays)

  • Had received cognitive-behavior therapy for Panic Disorder in the last six months

  • Cognitive impairment preventing the completion of psychological assessment

  • Past or present psychotic episode, Bipolar Disorder, or organic mental disorder

  • Current Abuse or Dependence Disorder

  • If another Mental Disorder is present, its severity was equal or inferior to the severity of Panic Disorder

  • Current medical condition preventing the participant from receiving pharmacological of cognitive-behavior treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôtel-Dieu de Lévis Lévis Quebec Canada G6V 3Z1
2 Institut de Cardiologie de Montréal (Montreal Heart Institute) Montréal Quebec Canada H1T 1C8
3 Hôpital du Sacré-Coeur de Montréal Montréal Quebec Canada H4J 1C5

Sponsors and Collaborators

  • Université du Québec a Montréal
  • Canadian Institutes of Health Research (CIHR)

Investigators

  • Principal Investigator: André Marchand, PhD, Université du Québec a Montréal

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00736346
Other Study ID Numbers:
  • MOP 81128 (CIHR)
First Posted:
Aug 15, 2008
Last Update Posted:
Aug 15, 2008
Last Verified:
Aug 1, 2008

Study Results

No Results Posted as of Aug 15, 2008